Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 4/20 | 0.61 |
| ▸ | CPT2 | P23786 | 1/20 | 0.61 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31390775 | 1.00 | ACLY (0.61) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL28219381 | 0.86 | ACLY (0.57) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL2979037 | 0.79 | CPT2 (0.53) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL260454 | 0.78 | CPT2 (0.41) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL10535147 | 0.78 | CPT2 (0.41) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL29482688 | 0.78 | ACLY (0.64) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL722576 | 0.78 | ACLY (0.64) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL10535133 | 0.78 | CPT2 (0.41) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL3979316 | 0.77 | ACLY (0.57) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL16753885 | 0.77 | CPT2 (0.42) | ACLYCPT2MEN1RECQLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3724307-B1 | LAUNDRY SURFACTANTS HAVING INHERENT BUILDING CAPACITY DERIVED FROM BIO-BASED HYDROYACIDS AND EPOXIDES; AND PROCESS THEREFORE | BATTELLE MEMORIAL INSTITUTE (US) | 2025-07-16 | — | — | EP | claimed |
| WO-2020239083-A1 | AEROSOL GENERATION OR SMOKING SYSTEM, OR ELECTRONIC CIGARETTE AND DEVICE THEREOF | 钟术光 | 2020-12-03 | — | — | WO | claimed |
| EP-0426557-B1 | Process for the preparation of 2-(3-pyridyl)-tetrahydrothiopyran-2-carbothiamide-1-(1R,2R)oxydes, the 2-(3-pyridyl)-tetrahydrothiopyran-2-carbothiamide-1-(1R,2R)oxydes and so obtained and pharmaceutical compositions containing them | RHONE POULENC SANTE (FR) | 1995-02-22 | — | — | EP | claimed |
| WO-2020239083-A1 | AEROSOL GENERATION OR SMOKING SYSTEM, OR ELECTRONIC CIGARETTE AND DEVICE THEREOF | 钟术光 | 2020-12-03 | — | — | WO | disclosed |
| CN-111602850-A | Aerosol generating or aerosolization system or electronic cigarette and device thereof | 钟术光 | 2020-09-01 | — | — | CN | disclosed |
| CN-110150760-A | A kind of aerosol generation system | 钟术光 | 2019-08-23 | — | — | CN | disclosed |
| CN-106139155-A | The pharmaceutical carrier of slow-release | 钟术光 | 2016-11-23 | — | — | CN | disclosed |
| CN-106074417-A | The pharmaceutical carrier of slow-release | 钟术光 | 2016-11-09 | — | — | CN | disclosed |
| CN-106075457-A | The pharmaceutical carrier of slow-release | 钟术光 | 2016-11-09 | — | — | CN | disclosed |
| CN-105854022-A | Drug carrier capable of slowly releasing drug | 钟术光 | 2016-08-17 | — | — | CN | disclosed |
| CN-102698277-B | Drug carrier for sustained release of drug | 钟术光 | 2016-08-03 | — | — | CN | disclosed |
| CN-103432091-A | Improved-performance tablet and preparation method thereof | ZHONG SHUGUANG | 2013-12-11 | — | — | CN | disclosed |
| CN-102698277-A | Drug carrier for sustained release of drug | SHUGUANG ZHONG | 2012-10-03 | — | — | CN | disclosed |
| US-20100152488-A1 | High Purity (-) Hydroxycitric Acid Metal Salt Derivatives and Method of Preparation of the Same | VITTAL MALLYA SCIENTIFIC RESEARCH FOUNDATION (IN) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152488-A1 | High Purity (-) Hydroxycitric Acid Metal Salt Derivatives and Method of Preparation of the Same | HACL2, HKDC1, HIPK1 | ACLY 1570/4885CPT2 2316/4885HSPD1 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.